Hartung HP - Search Results

1

Lower levels of N-acetylaspartate in multiple sclerosis patients with the apolipoprotein E epsilon4 allele.

Enzinger C, Ropele S, Strasser-Fuchs S, Kapeller P, Schmidt H, Poltrum B, Schmidt R, Hartung HP, Fazekas F. Enzinger C, et al. Among authors: hartung hp. Arch Neurol. 2003 Jan;60(1):65-70. doi: 10.1001/archneur.60.1.65. Arch Neurol. 2003. PMID: 12533090

2

Different effects of simvastatin and interferon beta on the proteolytic activity of matrix metalloproteinases.

Kieseier BC, Archelos JJ, Hartung HP. Kieseier BC, et al. Among authors: hartung hp. Arch Neurol. 2004 Jun;61(6):929-32. doi: 10.1001/archneur.61.6.929. Arch Neurol. 2004. PMID: 15210533

3

Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions.

Frohman EM, Filippi M, Stuve O, Waxman SG, Corboy J, Phillips JT, Lucchinetti C, Wilken J, Karandikar N, Hemmer B, Monson N, De Keyser J, Hartung H, Steinman L, Oksenberg JR, Cree BA, Hauser S, Racke MK. Frohman EM, et al. Arch Neurol. 2005 Sep;62(9):1345-56. doi: 10.1001/archneur.62.9.1345. Arch Neurol. 2005. PMID: 16157741 Review.

4

Clinical stabilization and effective B-lymphocyte depletion in the cerebrospinal fluid and peripheral blood of a patient with fulminant relapsing-remitting multiple sclerosis.

Stüve O, Cepok S, Elias B, Saleh A, Hartung HP, Hemmer B, Kieseier BC. Stüve O, et al. Among authors: hartung hp. Arch Neurol. 2005 Oct;62(10):1620-3. doi: 10.1001/archneur.62.10.1620. Arch Neurol. 2005. PMID: 16216948

5

Acute disseminated encephalomyelitis: an update.

Menge T, Hemmer B, Nessler S, Wiendl H, Neuhaus O, Hartung HP, Kieseier BC, Stüve O. Menge T, et al. Among authors: hartung hp. Arch Neurol. 2005 Nov;62(11):1673-80. doi: 10.1001/archneur.62.11.1673. Arch Neurol. 2005. PMID: 16286539 Review.

6

Inhibition by mitoxantrone of in vitro migration of immunocompetent cells: a possible mechanism for therapeutic efficacy in the treatment of multiple sclerosis.

Kopadze T, Dehmel T, Hartung HP, Stüve O, Kieseier BC. Kopadze T, et al. Among authors: hartung hp. Arch Neurol. 2006 Nov;63(11):1572-8. doi: 10.1001/archneur.63.11.1572. Arch Neurol. 2006. PMID: 17101825

7

Treatment of active secondary progressive multiple sclerosis with treosulfan.

Wiendl H, Kieseier BC, Weissert R, Mylius HA, Pichlmeier U, Hartung HP, Melms A, Kuker W, Weller M. Wiendl H, et al. Among authors: hartung hp. J Neurol. 2007 Jul;254(7):884-9. doi: 10.1007/s00415-006-0459-6. Epub 2007 Apr 20. J Neurol. 2007. PMID: 17446994

8

Subgroups of the BENEFIT study: risk of developing MS and treatment effect of interferon beta-1b.

Polman C, Kappos L, Freedman MS, Edan G, Hartung HP, Miller DH, Montalbán X, Barkhof F, Selmaj K, Uitdehaag BM, Dahms S, Bauer L, Pohl C, Sandbrink R; BENEFIT investigators. Polman C, et al. Among authors: hartung hp. J Neurol. 2008 Apr;255(4):480-7. doi: 10.1007/s00415-007-0733-2. Epub 2007 Nov 15. J Neurol. 2008. PMID: 18004635 Clinical Trial.

9

Persistence of immunopathological and radiological traits in multiple sclerosis.

König FB, Wildemann B, Nessler S, Zhou D, Hemmer B, Metz I, Hartung HP, Kieseier BC, Brück W. König FB, et al. Among authors: hartung hp. Arch Neurol. 2008 Nov;65(11):1527-32. doi: 10.1001/archneur.65.11.1527. Arch Neurol. 2008. PMID: 19001173

10

Long-term B-lymphocyte depletion with rituximab in patients with relapsing-remitting multiple sclerosis.

Stüve O, Leussink VI, Fröhlich R, Hemmer B, Hartung HP, Menge T, Kieseier BC. Stüve O, et al. Among authors: hartung hp. Arch Neurol. 2009 Feb;66(2):259-61. doi: 10.1001/archneurol.2008.551. Arch Neurol. 2009. PMID: 19204165

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,134 results

Search Page

Filters